IP Library Granted Patent US 9,192,518
Granted Patent B2
US 9,192,518 · App. 14/195,106 · Granted Nov 24, 2015

System for treating ophthalmic target tissue using a treatment pattern of lesions

Inventors: Daniel V. Palanker (Sunnyvale, CA); Dan Andersen (Menlo Park, CA)
Assignee: TOPCON MEDICAL LASER SYSTEMS, INC.
A61F9/008A61B18/20A61F9/00821A61B19/5212A61B2018/2085A61F2009/00855A61F2009/00863A61F2009/00868A61F2009/00897
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,192,518
App. No.
14/195,106
Granted
Nov 24, 2015
Kind
B2
Abstract

A system and method for treating ophthalmic target tissue, including a light source for generating a beam of light, a beam delivery system that includes a scanner for generating patterns, and a controller for controlling the light source and delivery system to create a dosimetry pattern of the light beam on the ophthalmic target tissue. One or more dosage parameters of the light beam vary within the dosimetry pattern, to create varying exposures on the target tissue. A visualization device observes lesions formed on the ophthalmic target tissue by the dosimetry pattern. The controller selects dosage parameters for the treatment beam based upon the lesions resulting from the dosimetry pattern, either automatically or in response to user input, so that a desired clinical effect is achieved by selecting the character of the lesions as determined by the dosimetry pattern lesions.

Claims (28)

1. A system for treating ophthalmic target tissue using a treatment pattern of lesions, wherein the treatment pattern comprises a first sub-pattern of lesions and a second sub-pattern of lesions, the system comprising:

a light source for generating a beam of light towards a beam delivery unit;

the beam delivery unit configured to deliver the beam of light to the ophthalmic target tissue, the beam delivery unit including a scanner unit configured to deflect the beam of light; and

a control unit operatively coupled to and configured to control at least one of the light source and the beam delivery unit to:

deliver the beam of light to the ophthalmic target tissue, wherein the delivery creates a first sub-pattern of lesions on the ophthalmic target tissue, the first sub-pattern including:

a plurality of ophthalmoscopically invisible lesions, and

at least one ophthalmoscopically visible lesion; and

a visualization device configured to identify an ophthalmoscopically visible lesion from the first sub-pattern of lesions, wherein the control unit is further configured to control a least one of the light source and the beam delivery unit to:

after creating the first sub-pattern, align the beam of light based on the identified ophthalmoscopically visible lesion from the first sub-pattern, and create the second sub-pattern of lesions on the ophthalmic target tissue using the aligned beam of light,

wherein the ophthalmoscopically visible lesion from the first sub-pattern indicates an end of the first sub-pattern, and

wherein the second sub-pattern is adjacent the first sub-pattern but does not overlap the first sub-pattern.

2. The system of claim 1 ,

wherein the control unit is further configured to adjust a pulse duration of the beam of light, and

wherein the plurality of ophthalmoscopically invisible lesions are formed using a shorter pulse duration of the beam of light and the at least one ophthalmoscopically visible lesion is formed using a longer pulse duration of the beam of light.

3. The system of claim 1 ,

wherein the control unit is further configured to adjust a power density of the beam of light, and

wherein the plurality of ophthalmoscopically invisible lesions are formed using a lower power density of the beam of light, and the at least one ophthalmoscopically visible lesion is formed using a higher power density of the beam of light.

4. The system of claim 1 ,

wherein the control unit is further configured to adjust a pulse duration and a power density of the beam of light, and

wherein the plurality of ophthalmoscopically invisible lesions are formed using a shorter pulse duration and a lower power density of the beam of light, and the at least one ophthalmoscopically visible lesion is formed using a longer pulse duration and a higher power density of the beam of light.

5. The system of claim 1 , wherein:

the first sub-pattern includes a first row of lesions.

6. The system of claim 2 , wherein:

the ophthalmoscopically visible lesion from the first sub-pattern that indicates an end of the first sub-pattern is the first lesion in the first row of lesions.

7. The system of claim 2 ,

wherein the first sub-pattern includes at least two rows of lesions,

wherein a first row of the at least two rows of lesions is aligned above a second row of the at least two rows of lesions,

wherein the ophthalmoscopically visible lesion from the first sub-pattern that indicates an end of the first sub-pattern is at one end of the second row of lesions.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: TOPCON MEDICAL LASER SYSTEMS, INC.
To: IRIDEX CORPORATION
Reel/Frame 056836/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2014
From: PALANKER, DANIEL V.; ANDERSEN, DAN
To: TOPCON MEDICAL LASER SYSTEMS, INC.
Reel/Frame 032789/0987 →
Continuity (4)
Division 13691691 · Nov 30, 2012
Continuation 11939398 · Nov 13, 2007
Provisional Application 60857951 · Nov 10, 2006
Related Publication 20140207127A1 · Jul 24, 2014